Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: | Nephrology | Oncology | Family Medicine | Urology
Search Medical Condition
Bladder Cancer Clinical Trials
A listing of Bladder Cancer medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Found (340) clinical trials
Phase I Dose Escalation Pan-FGFR (Fibroblast Growth Factor Receptor) Inhibitor
- This is the first study where BAY1163877 is given to humans. Impact of the study is to evaluate if patients with advanced solid cancers show advanced clinical benefit under the treatment with the pan FGFR inhibitor. Patients (all comers) will receive the study drug treatment in a dose-escalation scheme ...
AHEP0731: Combination Chemotherapy in Treating Young Patients with Newly Diagnosed Liver Cancer
For more information please visit: http://clinicaltrials.gov/ct2/show/NCT00980460?term=AHEP0731&rank=1
A Humanitarian Use Device trial for patients who have hepatocellular carcinoma of the liver.
A Humanitarian Use Device trial for patients who have hepatocellular carcinoma of the liver.
Blood Sample – Diagnosed With or At Risk for Hepatocellular Carcinoma
A research study is collecting blood samples to better understand biomarkers in adults recently diagnosed with or at risk for developing Hepatocellular Carcinoma (HCC). Those with hepatitis B or C, nonalcoholic steatohepatitis (NASH), cirrhosis or other forms of liver disease may be at risk.
Early-stage Hepatocellular Carcinoma
People with liver cirrhosis and recently diagnosed (not yet treated) early-stage hepatocellular carcinoma are asked to participate in a research study being conducted by Montefiore Medical Center.
Muscle- Invasive Bladder Cancer (MIBC)
People with bladder cancer are asked to participate in a research study being conducted by Montefiore Medical Center.
Muscle-Invasive Bladder Cancer
A research study is evaluating an investigational medication used in combination with Nivolumab (OPDIVO®) in those diagnosed with Muscle-Invasive Urothelial Carcinoma of the bladder.
Fierce-22: A Phase 1b/2 Study of Vofatamab (B-701) in Combination with Pembrolizumab in Treatment of Locally Advanced or Metastatic Urothelial Cell Carcinoma
The FIERCE-22 study is a Phase 1b/2 study to evaluate the effectiveness and safety of vofatamab (B-701) in combination with the immunotherapy drug pembrolizumab in the treatment of subjects with Stage IV, locally advanced or metastatic FGFR3 wild-type (WT) or mutation positive UCC who have previously been treated with a ...
A Phase II Clinical Trial to Study the Efficacy and Safety of Pembrolizumab (MK-3475) in Subjects With High Risk Non-muscle Invasive Bladder Cancer (NMIBC) Unresponsive to Bacillus Calmette-Guerin (BCG) Therapy
Patients who wish to enroll in a research study should discuss the possibilities with their urologist. The TUCC Clinical Research Department staff remains in constant communication with patients throughout their enrollment in clinical trials. These patients receive all study related medication and procedures at no cost. Participation is voluntary and ...
Low Grade (LG) Non-Muscle-Invasive Bladder Cancer (NMIBC)
People with Bladder Cancer are asked to participate in a research study being conducted by Montefiore Medical Center.
